CMS Implements Temporary Medicare Payment Boost for Qualifying Biosimilars
- October 07, 2022
Medicare has implemented a temporary increase in the add-on payment for qualifying biosimilars under the recently enacted Inflationary Reduction Act, the Centers for Medicare & Medicaid Services (CMS) announced October 3.
ARTICLE TAGS
You must be logged in to access this content.